Chronic kidney disease (CKD) is a progressive clinical condition that affects a growing number of people worldwide. While advances in haemodialysis techniques have led to notable improvements in survival rates and the quality of life (QoL) of patients with CKD (PwCKD), significant complications persist, primarily associated with chronic uremia. These include skeletal muscle atrophy, reduced muscular strength and diminished functional capacity. Recent studies support the role of systematic exercise as a non-pharmacological strategy to reduce issues and improve musculoskeletal function among haemodialysis patients. Specifically, intradialytic exercise gained ground due to its efficiency in time utilization and elimination of transport burden. Nevertheless, most of the intradialytic exercise programs implement aerobic exercise and there is a lack of studies investigating combined strength and aerobic exercise modalities, which may offer more comprehensive physiological benefits. The aim of the randomized controlled trial (RCT) is to examine whether a 6-month combined aerobic and resistance exercise program, implemented during haemodialysis sessions, could affect body composition, muscle oxygenation of the lower and upper extremities, and functional capacity of patients that underwent haemodialysis. Forty patients will be randomly allocated into two groups: Group A (Exercise Group) will undergo 3 sessions per week of an intradialytic exercise program for 6 months and Group B (Control Group) will receive the usual care without participating in organized exercise programs. Prior to the group random allocation, part of our assessments at baseline and after 6 (Evaluation A') will include demographics and clinical history, body composition analysis via bioelectrical impedance analysis, muscle oxygenation monitoring of the vastus lateralis and biceps brachii muscles at rest and during exercise using near-infrated spectroscopy (NIRS) technology. Functional capacity will be assessed through validated tests: Six-minute walk test (6MWT), 30-second sit-to-stand test, five-repetition sit-to-stand test (5STS), handgrip strength, 4-meter gait speed test. Additionally, we will use questionnaires assessing physical activity using International Physical Activity Questionnaire (IPAQ), depression using Beck Depression Inventory (BDI), stress using Generalized Anxiety Disorder 7-item scale(GAD-7) and the QoL using Kidney Disease Quality of Life Short Form(KDQOL-SF) of people that underwent dialysis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical and demographic characteristics
Timeframe: Baseline
Clinical and demographic characteristics
Timeframe: 6-month
Muscle oxygenation Assessment-MOXY
Timeframe: Baseline
Muscle oxygenation Assessment-MOXY
Timeframe: 6-month
Body composition analysis
Timeframe: Baseline
Body composition analysis
Timeframe: 6-month
Six minute walk test
Timeframe: Baseline
Six minute walk test
Timeframe: 6-month
JAMAR SMART Hand Dynamometer
Timeframe: Baseline
JAMAR SMART Hand Dynamometer
Timeframe: 6- month
30-second Sit-to-Stand Test
Timeframe: Baseline
30-second Sit-to-Stand Test
Timeframe: 6- month
Five-Repetition Sit-to-Stand Test (5STS)
Timeframe: Baseline
Five-Repetition Sit-to-Stand Test (5STS)
Timeframe: 6- month
4-Meter Gait Speed Test
Timeframe: Baseline
4-Meter Gait Speed Test
Timeframe: 6- month
International Physical Activity Questionnaire (IPAQ).
Timeframe: Baseline
International Physical Activity Questionnaire (IPAQ).
Timeframe: 6- month
Beck Depression Inventory (BDI)
Timeframe: Baseline
Beck Depression Inventory (BDI)
Timeframe: 6- month
Generalized Anxiety Disorder-7 scale (GAD-7).
Timeframe: Baseline
Generalized Anxiety Disorder-7 scale (GAD-7).
Timeframe: 6- month
Kidney Disease Quality of Life Short Form (KDQOL-SFâ„¢)
Timeframe: Baseline
Kidney Disease Quality of Life Short Form (KDQOL-SFâ„¢)
Timeframe: 6- month
Baseline leg dynamometer
Timeframe: Baseline
Baseline leg dynamometer
Timeframe: 6- month